EML4-ALK Rearrangement as a Mechanism of Resistance to Osimertinib in Metastatic Lung Adenocarcinoma: A Case Report

Xinyu von Buttlar, Joshua E. Reuss, Stephen V. Liu, Chul Kim

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'EML4-ALK Rearrangement as a Mechanism of Resistance to Osimertinib in Metastatic Lung Adenocarcinoma: A Case Report'. Together they form a unique fingerprint.

Medicine & Life Sciences